Maze Therapeutics

South San Francisco, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

Apr 2026

Post-IPO Equity

Biopharma Biotechnology Genetics Therapeutics

Top Investors

Andreessen HorowitzGeneral CatalystARCH Venture PartnersJanus Henderson InvestorsTCG Crossover

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Maze Therapeutics

Who are Maze Therapeutics's investors?

Maze Therapeutics's investors include Andreessen Horowitz, General Catalyst, ARCH Venture Partners, Janus Henderson Investors, TCG Crossover.

Where is Maze Therapeutics headquartered?

Maze Therapeutics is headquartered in South San Francisco, United States.

What does Maze Therapeutics do?

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

What stage is Maze Therapeutics at?

Maze Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 22, 2026.

MLA

"Maze Therapeutics — Funding & Investors." VCBacked, April 22, 2026, https://www.vcbacked.co/company/maze-therapeutics. Accessed June 3, 2026.

APA

VCBacked. (2026). Maze Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/maze-therapeutics

Wikipedia (cite web)

{{cite web |title=Maze Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/maze-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 22, 2026.

Similar Companies in Biopharma